Mechanism of interaction of three isoxazolyl penicillins, cloxacillin sodium, dicloxacillin sodium, and flucloxacillin sodium -with bovine serum albumin has been studied using fluorescence spectroscopic technique. The stoichiometry of the interaction was found to be 1:1, and association constants were of the order of 10 4 in each case. The nature of drug-protein interaction could be predicted from the thermodynamic parameters for the binding. High positive entropy changes and positive enthalpy changes indicated that hydrophobic interactions are predominantly involved in the binding of these drugs to serum albumin. Binding studies carried out in the presence of hydrophobic probe 1-anilinonaphthalene-8-sulfonate (ANS) showed that the drugs and ANS do not share a common site on the albumin molecule. Stern-Volmer analysis of the fluorescence data showed that both the tryptophan residues of albumin are involved; but they are not fully accessible to the drugs, and static quenching mechanism is operative.
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. cyclic amide and are susceptible to chemical and enzymatic degradation. Acids, bases, and enzyme β-Barbosa et al. [8] [9] and others 10 have used a range of lactamase directly attack the beta lactam bond and physicochemical properties such as solution conductivity, inactivate the antibiotic 1 . β-lactamases are not particularly electrokinetic behaviour, partial specific volume and tolerant to steric hindrance when it occurs at the side adiabatic compressibility to study the interaction of chain amide. The antibiotics cloxacillin, dicloxacillin, and cloxacillin and dicloxacillin with human serum albumin. flucloxacillin in which a substituted isoxazolyl ring system Some work on the binding of isoxazolyl penicillins with is used as a bioisosteric replacement for the benzyl group serum albumin using microcalorimetric and ultrafiltration in penicillin G are β-lactamase-resistant semi-synthetic technique has also been reported [11] [12] . Although these penicillins 2 . They are also sufficiently acid-stable to be drugs are being frequently prescribed, no recent detailed taken orally 3 .
study on the mechanism of binding of isoxazolyl penicillins with serum albumin using spectroscopic Isoxazolyl penicillins are highly bound to serum proteins, methods is available. In the present paper, binding mainly albumin 4 , and therefore, small changes in binding parameters and the nature of forces involved in the have a large effect on the proportion of free interaction of three drugs cloxacillin sodium, dicloxacillin pharmacologically active drug in plasma. Thus, the nature sodium and flucloxacillin sodium with bovine serum and magnitude of the interaction of penicillins with serum albumin has been studied using fluorescence albumin has important pharmacokinetic and spectroscopic technique. Human and bovine serum pharmacodynamic implications and is a determinant factor albumin exhibit similar binding chemistry due to the high in their therapeutic properties [5] [6] . High serum protein percentage of sequence identities between the two binding has several other major effects, including proteins 13 . restricted tissue distribution, reduced penetration into interstitial spaces and inflammatory fluids, delayed various manufacturers. Serum albumin, bovine (BSA), and fluorescent probe 1-anilinonaphthalene-8-sulfonate (ANS) were purchased from Sigma Chemical Co., St. Louis, U.S.A. All other reagents were of analytical grade. Water used was double distilled in all-glass apparatus. BSA solutions were prepared based on molecular weight of 66,000. All experiments were carried out in 0.10 M phosphate buffer using fluorescence spectroscopic technique. Perkin Elmer fluorescence spectrophotometer (MPF 44B) equipped with a 150 W xenon lamp source was used.
Determination of binding parameters:
For the determination of binding parameters, 2 ml of 10 µM albumin solution was taken in a quartz cell and increasing amounts of drug stock solution (500 µM) was added. Albumin concentration was kept fixed at 10 µM by adding the same volume of 20 µM albumin to the cell. Fluorescence spectra were recorded in the range of 280 400 nm after excitation at 295 nm, in each case. Intrinsic fluorescence of protein was measured; drugs used did not have any fluorescence at the emission wavelength of protein. No correction for inner filter effect was applied since the drugs had very low absorbance (less than 0.05) at the excitation and emission wavelengths.
Stoichiometry of the drug-protein interaction was determined by the method of continuous variations [14] [15] The fluorescence change (∆F = F protein+drug -F protein ) of a series of protein-drug mixtures was measured under such conditions that the total concentration of 'drug plus protein' was held constant at 10 µM, but the respective mole fraction of each was varied. ∆F was plotted against the mole fraction of drug (Job's plot), and the stoichiometry of binding was obtained from the maximum in the plot, in each case.
Data analysis:
Data was analysed as follows using Ward method 16 . The fractional occupancy of the total protein binding sites by drug was obtained from the ratio θ = ∆F/∆F max [17] [18] where ∆F = F 0 -F, F 0 and F are the fluorescence intensities of serum albumin in the absence and presence of drug, respectively. ∆F max values were obtained from the double reciprocal (1/∆F versus 1/D t ) plots.
If P t is the total protein concentration and n is the number of binding sites, the total number of sites on protein is given by nP t , and the concentration of bound sites on protein is given by nθP t
16
, which is also equal to the concentration of the bound drug (D b ). D f , the number of moles of free drug, was obtained from the difference D t -D b , where D t is the total drug added. The amount bound was expressed as moles of drug bound per mole of protein, (r = D b /P t ). The binding parameters were computed directly by fitting the experimental data (r and D f values) to the following general equation (Scatchard equation) using an iterative non-linear least squares regression program developed for this purpose:
The association constant (K) and the number of binding sites (n) were determined at three different temperatures (10, 17 , and 27°), and the thermodynamic parameters for binding were calculated using equations ∆G° = -RT ln K -(2) and log K = -∆H°/2.303RT + ∆S°/2.303R -
.
Binding studies in the presence of hydrophobic probe ANS:
Experiments were also carried out in the presence of hydrophobic probe ANS [19] [20] . In the first set of experiments, interaction of drugs and ANS with albumin was studied under identical conditions. Albumin concentration was kept fixed at 10 µM and ANS/drug concentration was varied from 2 to 15 µM. Fluorescence of albumin was recorded in the range 280-400 nm after .
excitation at 295 nm. In the second set of experiments, albumin-ANS interaction was studied in the presence and absence of increasing concentrations of the drug. The fluorescence of ANS was recorded in the range 350 to 500 nm after excitation at 370 nm. Increasing amounts of drug was added to an equimolar albumin-ANS mixture (10 µM each). The drug concentration was varied from 10 µM to 75 µM and the concentration of albumin-ANS mixture was kept fixed at 10 µM each by adding the same volume of albumin-ANS mixture (20 µM each) to the cell. The percentage displacement of probe (D) was calculated using the relationship D = (F 1 -F 2 )/F 1 × 100, where F and F are the fluorescence intensities of ANS 1 2 , in the absence and presence of drug, respectively.
RESULTS AND DISCUSSION
Bovine serum albumin (BSA) represents 52-60% of the total plasma protein and is the major binding protein for anionic drugs. BSA consists of a chain of 580 amino acid residues forming a single polypeptide that contains three domains (I-III) and two tryptophan residues, located at position 134 in subdomain IB and position 212 in subdomain IIA 21 . Intrinsic fluorescence of BSA was 1.6 measured by selectively exciting the tryptophan residues different drug:protein ratios was calculated from the data and is given in Table 1 . The values were found to decrease with increase in the drug:protein ratio. At low drug:protein ratios, a significant fraction of the added drug was bound in each case. It may be mentioned that low drug:protein ratios are frequently encountered in the physiological system since in blood, the serum albumin concentration is very large (0.53-0.75 mM).
The association constants for the binding, determined by the non-linear least squares regression program, are given in Table 2 . The experimental data could be fitted into an equation for only one class of binding sites (m=1). Association constants were of the order of 10
4
. The order of association constants was dicloxacillin> cloxacillin> flucloxacillin. The nature of drug-protein interaction could be predicted from the thermodynamic parameters for the binding. Thermodynamic parameters for the binding, determined from the temperature-dependence of the association constants, are given in Table 3 . For electrostatic interactions, ∆H° has a very small negative value, nearly zero 15, 22 . In the present case, high positive enthalpy changes indicate that electrostatic interactions are not present. This can also be inferred from the fact that at physiological pH, drugs as well as BSA are in predominantly anionic form. Positively charged side chain residues of protein do not appear to be involved in binding. Both ∆H° and ∆S° were found to be positive in 24 and others 11 , using microcalorimeteric technique, have also shown that for cloxacillin and dicloxacillin, the interaction is essentially hydrophobic in nature.
In order to further understand the nature of interaction involved, binding was also studied in the presence of hydrophobic probe ANS. Under identical conditions, whereas ANS could quench about 70% of protein fluorescence, the drugs used could quench only 10-15% of the protein fluorescence. Thus, the percentage quenching of protein fluorescence by drugs was much less as compared to the quenching by ANS. It thus appears that the drugs and ANS do not share common site on the albumin molecule. ANS fluorescence was also measured in albumin-ANS mixture in the absence and presence of increasing amounts of drug. It was found that in each case, the presence of drug caused only a small decrease in the fluorescence of ANS. The effect was quantitatively studied by determining the percentage displacement of probe ANS (D). The results showed that up to a drug:protein ratio of 7:1, only 3-6% of drugs were displaced, which again leads to the conclusion that the drugs and ANS do not share common site on albumin.
Stern-Volmer analysis of fluorescence data is useful in the estimation of the accessibility of tryptophan residues in proteins to the drug (quencher) molecules. Fluorescence quenching data was therefore analysed by the modified Stern-Volmer equation 25 , 26 have suggested that the environment of the tryptophan residue located at position 134 of BSA has higher polarity than the tryptophan located at position 212. Since the drugs used are relatively polar in nature due to the presence of carboxyl group, it appears that tryptophan 134 is more easily accessible than tryptophan 212 in the binding of these drugs to BSA. No explanation could be found for the exceptionally low f a value (0.38) in the case of dicloxacillin at 300.15 K. The observation that the quenching constants are close to the association constants for the interaction indicate that the quenching mechanism essentially involves static quenching 27 . It may thus be concluded that isoxazolyl penicillins are bound to serum albumin on a single site with moderate affinity. The binding is predominantly through hydrophobic interactions. Studies carried out in the presence of hydrophobic probe showed that the drugs and ANS do not share a common site on the albumin molecule. Stern-Volmer analysis of the fluorescence data showed that both the tryptophan residues of BSA are involved in binding, but tryptophan 134 is more easily accessible to these drugs than tryptophan 212. Moreover, static quenching mechanism appears to be involved in the case of all the drugs. 
